Introduction
The emergence of a community pathogen depends on its ability to survive in different environments and to interact successfully with the host. Staphylococcus aureus is one of the successful and adaptable human pathogens 1 . Staphylococcus aureus has a broad pathogenic potential causing a wide range of community acquired as well as nosocomial infections 2 . The organism has been found to be the most common bacterial agent recovered from blood stream infections, skin and soft tissue infections, pneumonia and hospital -acquired postoperative wound infections 3 . Also it can cause a variety of infections ranging from relatively minor skin infections, to life-threatening systemic illnesses such as meningitis, endocarditis, septic arthritis, osteomyelitis, subcutaneous or visceral abscesses, toxic shock syndrome (TSS), Staphylococcal scalded skin syndrome (SSSS) and septicemia. Staphylococcus aureus infections are associated with morbidity in hospitals and community 4 . Serious endemic and epidemic Methicillin Resistant Staphylococcus Aureus (MRSA) infections occur globally. Methicillin resistant Staphylococcus aureus infection was initially reported in 1961, the same year in which methicillin (a penicillinase -resistant semi synthetic penicillin) was introduced. In1982, a "community -acquired outbreak" of MRSA, outside of a hospital, was first reported in intravenous drug users in Detroit, Michigan. During the 1990s, numerous outbreak of community acquired MRSA (CAMRSA). Indeed, the initial publication in the medical literature describing CAMRSA skin infections as "an emerging epidemic" 6 . Many strains of MRSA exhibit resistance to β-lactams and amino glycosides. Therefore, the knowledge of prevalence of MRSA and their current antimicrobial profile become necessary in the selection of appropriate empirical treatment of these infections. Hence the present study was conducted at Chhattisgarh region of India.
Material and methods
A total of one hundred and fifty different samples from different clinical specialties like surgery, orthopedics, pediatrics, gynecology and obstetrics, medicine were collected and processed for culture and sensitivity. This study was carried out between the period September 2013 to April 2014 out in the Department of Microbiology, CM Medical College and Hospital, Durg. All clinical specimens such as urine, pus, sputum/throat swab, blood, pleural fluid, catheter tip, tracheal and nasal swabs and vaginal swabs were collected for Staphylococcus aureus screening. All the samples were aseptically handled and processed 7 . Epidemiological parameters were recorded. An emphasis was made to record down whether the patient was on antimicrobial therapy, if yes, the duration of course and name of antibiotics.
Results
A total of 150 isolates from different clinical specimens were studied in which males were 76 (50.66%) and females 74 (49.33%). Majority were from surgical wards 33.33% (50), in that MRSA was 30% (15) and MSSA was 70% (35) followed by medicine wards 23.33% (35), in that MRSA and MSSA were 28.57% (10) . Least number of cases was seen in ophthalmology department as total number of cases was 2 in which 1 was MRSA and 1 MSSA (Table-1) . MRSA was seen in 27 out of 76 males comprising 35.52% whereas in case of females it was 25.67% i.e. 19 out of 74 cases. . This implies that the incidence of infection by MRSA isolates keeps changing every year and it is on a rise compared to last few years 10 . Risk factors that have been associated with MRSA acquisition include older age, prolonged hospitalization, prior antibiotic therapy, more severe underlying disease and degree of disability, surgical procedures, presence in an intensive care or burn unit, having a surgical wound infection, intravascular devices, mechanical ventilation, tracheostomy, pressure ulcers, or exposure to other infected or colonized individuals. Not only does antibiotic therapy predispose patients to colonization with MRSA, but it also increases the risk of invasive disease and infection. Other host factors associated with progression from colonization to infection include recent hospitalization, preceding surgical or wound debridement, and the number of invasive procedure 4 . In the present study, the antibiotic sensitivity results showed that all MRSA isolates were significantly more resistant to various antibiotics. The resistance of MRSA to β-lactams like Penicillin was 84.78% while co-trimoxazole resistance was seen in 80% of the isolates, which was much higher than the resistance obtained in another study in 1999 to 2004 (13.3%) and in 1997 to 1998 (45.4%) from the different institution 3 . In our study the spectrum of antimicrobial resistance among MRSA, quinolones (Ciprofloxacin) was also found to be high i.e 56.09%. This co-relates with an earlier finding where it has been shown that the resistance to ciprofloxacin is steadily increasing from 39% in 1992 to 68% in 1996 (5) . In 1997 also a high incidence of ciprofloxacin resistance (95.8%) was reported 11 . Again the resistance to ciprofloxacin is decreasing from 59.1% in 1999 -2004 3 . However, Pulimood had observed only 8% resistance of MRSA to gentamycin, as against 52.17% in our study. Gentamycin resistance is on rise since 1996. An increase of gentamycin o% before 1996 to 80% after 1996 has been reported. Qureshi had reported a gentamycin resistance of 97.8%, which is higher compared to our study 10 . But in the present study 65.21% of the strains were resistant to clindamycin, which is the same for erythromycin. All the MRSA isolates were found to be susceptible to vancomycin (100%) and rifampicin (100%), MRSA also showed high level of resistance to amoxicillin. The resistant rate to amikacin and nalidixic acid were 32.55% and 85.71%. An important feature of MRSA is their propensity to spread and colonize debilitated patients. Since these strains tend to be multiple antibiotic-resistant, they pose a major difficulty in treating systemic infections. MRSA are more pathogenic than methicillin-sensitive Staphylococcus aureus, especially in the seriously ill and immunosuppressed patients. Both can cause a spectrum of illnesses ranging from minor skin infections to life-threatening complication like bacteremia and pneumonia.
Conclusion
The choice of appropriate antimicrobial agents for suspected Staphylococcus aureus infections should be judicious.
Although many antimicrobials are ineffective but at least vancomycin seems to be the only antimicrobial agent which showed 100% sensitivity and may be used as the drug of choice for treating multidrug resistant MRSA infections. Further, the regular surveillance of hospital associated infections including monitoring antibiotic sensitivity pattern of MRSA and formulation of definite antibiotic policy may be helpful for reducing the incidence of MRSA infection.
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